|Non-Equity Incentive Plan||$420,875|
Ingram received $44.5M in option awards, accounting for 78.23% of the total pay in 2017.
Ingram also received $420.9K in non-equity incentive plan, $337.5K in salary, $11.6M in stock awards and $16.1K in other compensation.
20out of 13,853
Douglas Ingram's 2017 compensation ranked 20th out of 13,853 executive pay records tracked by us this year.
Ingram earned more than 99.9% of all executives tracked by us in 2017.
Ranking in industry group
1out of 1,584
In the industry group of Drugs, Ingram's pay ranked 1st out of 1,584 executive pay records tracked by us in 2017.
Ingram earned more than 99.9% of executives in this group.
We found six more compensation records of executives who worked with Douglas Ingram at Sarepta Therapeutics in 2017.
Chief Executive Officer
Chief Scientific Officer
Senior Vice President, Chief Commercial Officer
Chief Financial Officer